nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—DRD2—nicotine dependence	0.817	1	CbGaD
Amisulpride—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00681	0.0744	CcSEcCtD
Amisulpride—DRD3—Dopamine receptors—DRD2—nicotine dependence	0.00673	0.0821	CbGpPWpGaD
Amisulpride—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00644	0.0704	CcSEcCtD
Amisulpride—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.00624	0.0762	CbGpPWpGaD
Amisulpride—Suicide attempt—Varenicline—nicotine dependence	0.00589	0.0643	CcSEcCtD
Amisulpride—Menstrual disorder—Varenicline—nicotine dependence	0.0049	0.0536	CcSEcCtD
Amisulpride—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.00478	0.0583	CbGpPWpGaD
Amisulpride—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00444	0.0485	CcSEcCtD
Amisulpride—Alizapride—DRD2—nicotine dependence	0.00408	0.464	CrCbGaD
Amisulpride—Endocrine disorder—Varenicline—nicotine dependence	0.00403	0.044	CcSEcCtD
Amisulpride—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00402	0.0491	CbGpPWpGaD
Amisulpride—Aggression—Varenicline—nicotine dependence	0.0038	0.0416	CcSEcCtD
Amisulpride—Pulmonary embolism—Varenicline—nicotine dependence	0.00334	0.0365	CcSEcCtD
Amisulpride—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.00328	0.04	CbGpPWpGaD
Amisulpride—Salivary hypersecretion—Varenicline—nicotine dependence	0.00325	0.0355	CcSEcCtD
Amisulpride—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00308	0.0376	CbGpPWpGaD
Amisulpride—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00289	0.0352	CbGpPWpGaD
Amisulpride—DRD3—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.00262	0.032	CbGpPWpGaD
Amisulpride—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.00251	0.0306	CbGpPWpGaD
Amisulpride—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00221	0.027	CbGpPWpGaD
Amisulpride—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD2—nicotine dependence	0.00213	0.026	CbGpPWpGaD
Amisulpride—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.00201	0.0245	CbGpPWpGaD
Amisulpride—Remoxipride—DRD2—nicotine dependence	0.00199	0.227	CrCbGaD
Amisulpride—Erectile dysfunction—Varenicline—nicotine dependence	0.00193	0.0211	CcSEcCtD
Amisulpride—Weight increased—Varenicline—nicotine dependence	0.00191	0.0208	CcSEcCtD
Amisulpride—Hyperglycaemia—Varenicline—nicotine dependence	0.00189	0.0207	CcSEcCtD
Amisulpride—Depression—Varenicline—nicotine dependence	0.00186	0.0204	CcSEcCtD
Amisulpride—HTR7—Monoamine GPCRs—DRD2—nicotine dependence	0.00175	0.0213	CbGpPWpGaD
Amisulpride—Bradycardia—Varenicline—nicotine dependence	0.00171	0.0187	CcSEcCtD
Amisulpride—Sulpiride—DRD2—nicotine dependence	0.00167	0.19	CrCbGaD
Amisulpride—HTR2B—Monoamine GPCRs—DRD2—nicotine dependence	0.0016	0.0195	CbGpPWpGaD
Amisulpride—Cardiac disorder—Varenicline—nicotine dependence	0.00156	0.017	CcSEcCtD
Amisulpride—Angiopathy—Varenicline—nicotine dependence	0.00152	0.0166	CcSEcCtD
Amisulpride—Immune system disorder—Varenicline—nicotine dependence	0.00152	0.0166	CcSEcCtD
Amisulpride—DRD3—Monoamine GPCRs—DRD2—nicotine dependence	0.00149	0.0181	CbGpPWpGaD
Amisulpride—Mental disorder—Varenicline—nicotine dependence	0.00147	0.0161	CcSEcCtD
Amisulpride—HTR7—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00147	0.0179	CbGpPWpGaD
Amisulpride—Malnutrition—Varenicline—nicotine dependence	0.00146	0.016	CcSEcCtD
Amisulpride—Muscle spasms—Varenicline—nicotine dependence	0.0014	0.0153	CcSEcCtD
Amisulpride—Tremor—Varenicline—nicotine dependence	0.00137	0.015	CcSEcCtD
Amisulpride—HTR2B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00134	0.0164	CbGpPWpGaD
Amisulpride—Agitation—Varenicline—nicotine dependence	0.00134	0.0147	CcSEcCtD
Amisulpride—Angioedema—Varenicline—nicotine dependence	0.00133	0.0146	CcSEcCtD
Amisulpride—Convulsion—Varenicline—nicotine dependence	0.00127	0.0138	CcSEcCtD
Amisulpride—Hypertension—Varenicline—nicotine dependence	0.00126	0.0138	CcSEcCtD
Amisulpride—DRD3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00125	0.0153	CbGpPWpGaD
Amisulpride—Anxiety—Varenicline—nicotine dependence	0.00124	0.0135	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00124	0.0135	CcSEcCtD
Amisulpride—Dry mouth—Varenicline—nicotine dependence	0.00122	0.0133	CcSEcCtD
Amisulpride—Nervous system disorder—Varenicline—nicotine dependence	0.00117	0.0128	CcSEcCtD
Amisulpride—Skin disorder—Varenicline—nicotine dependence	0.00116	0.0127	CcSEcCtD
Amisulpride—Hyperhidrosis—Varenicline—nicotine dependence	0.00115	0.0126	CcSEcCtD
Amisulpride—HTR2A—Monoamine GPCRs—DRD2—nicotine dependence	0.00112	0.0137	CbGpPWpGaD
Amisulpride—Hypotension—Varenicline—nicotine dependence	0.00111	0.0122	CcSEcCtD
Amisulpride—Insomnia—Varenicline—nicotine dependence	0.00108	0.0118	CcSEcCtD
Amisulpride—Somnolence—Varenicline—nicotine dependence	0.00106	0.0116	CcSEcCtD
Amisulpride—Dyspepsia—Varenicline—nicotine dependence	0.00105	0.0115	CcSEcCtD
Amisulpride—Metoclopramide—DRD2—nicotine dependence	0.00105	0.119	CrCbGaD
Amisulpride—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00103	0.0112	CcSEcCtD
Amisulpride—Fatigue—Varenicline—nicotine dependence	0.00103	0.0112	CcSEcCtD
Amisulpride—Constipation—Varenicline—nicotine dependence	0.00102	0.0111	CcSEcCtD
Amisulpride—DRD3—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00101	0.0124	CbGpPWpGaD
Amisulpride—Gastrointestinal pain—Varenicline—nicotine dependence	0.000975	0.0107	CcSEcCtD
Amisulpride—Urticaria—Varenicline—nicotine dependence	0.000947	0.0103	CcSEcCtD
Amisulpride—Abdominal pain—Varenicline—nicotine dependence	0.000942	0.0103	CcSEcCtD
Amisulpride—HTR2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000941	0.0115	CbGpPWpGaD
Amisulpride—Hypersensitivity—Varenicline—nicotine dependence	0.000878	0.0096	CcSEcCtD
Amisulpride—Asthenia—Varenicline—nicotine dependence	0.000855	0.00935	CcSEcCtD
Amisulpride—Pruritus—Varenicline—nicotine dependence	0.000843	0.00922	CcSEcCtD
Amisulpride—Diarrhoea—Varenicline—nicotine dependence	0.000816	0.00891	CcSEcCtD
Amisulpride—Dizziness—Varenicline—nicotine dependence	0.000788	0.00861	CcSEcCtD
Amisulpride—DRD2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000776	0.00947	CbGpPWpGaD
Amisulpride—Vomiting—Varenicline—nicotine dependence	0.000758	0.00828	CcSEcCtD
Amisulpride—Headache—Varenicline—nicotine dependence	0.000747	0.00816	CcSEcCtD
Amisulpride—HTR7—GPCR ligand binding—TAS2R16—nicotine dependence	0.000722	0.00882	CbGpPWpGaD
Amisulpride—Nausea—Varenicline—nicotine dependence	0.000708	0.00774	CcSEcCtD
Amisulpride—HTR2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00066	0.00806	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000655	0.00799	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—TAS2R16—nicotine dependence	0.000614	0.0075	CbGpPWpGaD
Amisulpride—HTR7—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000557	0.0068	CbGpPWpGaD
Amisulpride—DRD3—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000474	0.00578	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00047	0.00574	CbGpPWpGaD
Amisulpride—HTR7—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000467	0.0057	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000462	0.00564	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000437	0.00533	CbGpPWpGaD
Amisulpride—DRD3—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000428	0.00522	CbGpPWpGaD
Amisulpride—HTR2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000427	0.00521	CbGpPWpGaD
Amisulpride—HTR7—Circadian rythm related genes—DRD2—nicotine dependence	0.000412	0.00503	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000408	0.00498	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0004	0.00488	CbGpPWpGaD
Amisulpride—DRD3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000397	0.00484	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000397	0.00484	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000373	0.00455	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—TAS2R16—nicotine dependence	0.000371	0.00452	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000365	0.00446	CbGpPWpGaD
Amisulpride—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000363	0.00443	CbGpPWpGaD
Amisulpride—DRD3—Circadian rythm related genes—DRD2—nicotine dependence	0.00035	0.00428	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000347	0.00424	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00034	0.00415	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000339	0.00413	CbGpPWpGaD
Amisulpride—HTR7—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000337	0.00412	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000327	0.00399	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—FGD1—nicotine dependence	0.00032	0.00391	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—TAS2R16—nicotine dependence	0.000315	0.00385	CbGpPWpGaD
Amisulpride—DRD3—G alpha (i) signalling events—DRD2—nicotine dependence	0.000309	0.00377	CbGpPWpGaD
Amisulpride—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000308	0.00376	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—OPRM1—nicotine dependence	0.000305	0.00372	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000304	0.00371	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000299	0.00365	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000293	0.00357	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—FGD1—nicotine dependence	0.000291	0.00355	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000289	0.00353	CbGpPWpGaD
Amisulpride—DRD3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000287	0.0035	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000278	0.0034	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—FGD1—nicotine dependence	0.000272	0.00332	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—FGD1—nicotine dependence	0.000266	0.00324	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000266	0.00324	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000264	0.00322	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000261	0.00319	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00026	0.00318	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—OPRM1—nicotine dependence	0.000259	0.00316	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000256	0.00312	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—FGD1—nicotine dependence	0.000247	0.00302	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000246	0.003	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000241	0.00294	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000237	0.0029	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—DRD2—nicotine dependence	0.00022	0.00269	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TAS2R16—nicotine dependence	0.000219	0.00267	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000216	0.00264	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000208	0.00254	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000205	0.0025	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.000201	0.00246	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.0002	0.00244	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000198	0.00242	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000195	0.00238	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000189	0.00231	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—DRD2—nicotine dependence	0.000187	0.00228	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000186	0.00227	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TAS2R16—nicotine dependence	0.000186	0.00227	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000185	0.00226	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—OPRM1—nicotine dependence	0.000172	0.0021	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—FGD1—nicotine dependence	0.000172	0.0021	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000157	0.00192	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—FGD1—nicotine dependence	0.000157	0.00192	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—OPRM1—nicotine dependence	0.000156	0.00191	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKR1B10—nicotine dependence	0.000152	0.00185	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—OPRM1—nicotine dependence	0.000146	0.00179	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—FGD1—nicotine dependence	0.000146	0.00178	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000143	0.00174	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.000142	0.00174	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000141	0.00172	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.00014	0.00171	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000139	0.00169	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—OPRM1—nicotine dependence	0.000133	0.00162	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKR1B10—nicotine dependence	0.000129	0.00158	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—DRD2—nicotine dependence	0.000124	0.00152	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	0.000114	0.00139	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—DRD2—nicotine dependence	0.000113	0.00138	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000112	0.00137	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGD1—nicotine dependence	0.000112	0.00136	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.00011	0.00134	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGD1—nicotine dependence	0.00011	0.00134	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—WASF2—nicotine dependence	0.000107	0.00131	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—DRD2—nicotine dependence	0.000106	0.00129	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	0.000103	0.00126	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—WASF1—nicotine dependence	0.000103	0.00125	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	0.000102	0.00124	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	0.0001	0.00122	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	9.88e-05	0.00121	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—WASF2—nicotine dependence	9.77e-05	0.00119	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	9.72e-05	0.00119	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—DRD2—nicotine dependence	9.61e-05	0.00117	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—WASF1—nicotine dependence	9.37e-05	0.00114	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—OPRM1—nicotine dependence	9.23e-05	0.00113	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—WASF2—nicotine dependence	9.09e-05	0.00111	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—WASF1—nicotine dependence	8.72e-05	0.00106	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	8.44e-05	0.00103	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	7.97e-05	0.000972	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—OPRM1—nicotine dependence	7.85e-05	0.000958	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	7.23e-05	0.000883	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—WASF2—nicotine dependence	6.96e-05	0.000849	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—WASF2—nicotine dependence	6.85e-05	0.000836	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—DRD2—nicotine dependence	6.67e-05	0.000815	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—WASF1—nicotine dependence	6.67e-05	0.000814	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—WASF1—nicotine dependence	6.56e-05	0.000801	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—DRD2—nicotine dependence	6.1e-05	0.000744	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—OPRM1—nicotine dependence	6.01e-05	0.000733	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	5.91e-05	0.000721	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—DRD2—nicotine dependence	5.68e-05	0.000693	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—DRD2—nicotine dependence	4.27e-05	0.000521	CbGpPWpGaD
